Atlas Trials

Long-term Evaluation of the Efficacy and Safety of Splentis for the Treatment of Primary Apical Pelvic Organ Prolapse

Clinical trial NCT05042453 · RECRUITING

Trial details

NCT number
NCT05042453
Sponsor
Promedon
Status
RECRUITING
Study type
OBSERVATIONAL
Pelvic Organ Prolapse
Start date
2022-12-19
Primary completion
2026-07-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.